Skip to main content

Table 2 Pre-/Post IV Treatment Data – 39 Patients Percent Predicted, Pre- and Post- infusion with % improvement

From: Short and long term treatment of asthma with intravenous nutrients

    FVC (L) FEV 1 (L) PEF (L/S) FEF 25–75 (L/S) FEF 75–85 (L/S)
  Sex Age % Predicted % Predicted % Predicted % Predicted % Predicted
Patient    Pre Post % Pre Post % Pre Post % Pre Post % Pre Post %
A, L. M 55 36 72 100% 36 79 119% 64 92 44% 35 129 269% 32 112 250%
A, S. F 48 28 50 79% 30 48 60% 40 78 95% 30 40 33% 40 38 -5%
B, M. F 57 69 100 45% 48 81 69% 45 115 156% 24 39 63% 30 32 7%
B, R. M 46 73 93 27% 69 87 26% 95 106 12% 57 70 23% 66 67 2%
B, V. F 39 34 67 97% 34 72 112% 51 59 16% 38 96 153% 26 98 277%
B, V. F 70 38 54 42% 32 47 47% 32 53 66% 18 30 67% 25 34 36%
C, D. M 59 27 30 11% 14 17 21% 10 12 20% 10 10 0% 32 28 -13%
C, A. F 33 90 91 1% 80 98 23% 115 142 23% 60 108 80% 65 116 78%
C, K. F 35 45 62 38% 34 52 53% 32 56 75% 22 36 64% 32 41 28%
D, C. F 33 65 65 0% 49 56 14% 62 65 5% 31 41 32% 42 51 21%
D, B. M 49 65 80 23% 72 83 15% 68 88 29% 75 80 7% 146 147 1%
D, K. F 48 61 74 21% 56 70 25% 89 95 7% 39 60 54% 29 33 14%
F, L. M 58 26 29 12% 12 13 8% 7 8 14% 7.4 8.1 9% 22 26 18%
G, W. M 74 48 67 40% 25 57 128% 16 88 450% 11 37 236% 38 63 66%
G, B. M 45 83 113 36% 83 101 22% 94 149 59% 81 70 -14% 89 60 -33%
G, G. F 42 83 93 12% 46 82 78% 24 59 146% 31 66 113% 55 79 44%
G, L. F 63 50 78 56% 36 60 67% 52 71 37% 17 29 71% 21 29 38%
J, E. F 63 47 85 81% 38 84 121% 43 64 49% 19 79 316% 20 55 175%
K, H. F 49 58 72 24% 59 72 22% 82 99 21% 53 62 17% 76 86 13%
M, A. F 46 85 97 14% 79 89 13% 61 86 41% 71 71 0% 73 68 -7%
M, W. M 85 74 77 4% 69 90 30% 46 82 78% 50 119 138% 148 458 209%
M, C. F 36 93 85 -9% 52 53 2% 30 46 53% 26 25 -4% 26 25.5 -2%
M, J. M 64 74 75 1% 49 57 16% 47 60 28% 25 37 48% 57 83 46%
O, M F 49 90 99 10% 98 114 16% 88 167 90% 114 168 47% 145 214 48%
P, O. F 47 54 72 33% 52 76 46% 85 84 -1% 46 82 78% 40 74 85%
R, B. F 69 21 23 10% 16 19 19% 13 17 31% 10 11 10% 21 22 5%
S, M. F 60 56 94 68% 45 88 96% 60 104 73% 26 66 154% 26 51 96%
S, J. M 54 98 166 69% 76 96 26% 77 70 -9% 34 39 15% 70 90 29%
S, S. M 40 73 85 16% 58 69 19% 68 85 25% 36 40 11% 43 38 -12%
S, D. F 64 40 56 40% 25 33 32% 18 21 17% 15 14 -7% 42 34 -19%
S, W. M 44 71 80 13% 52 65 25% 42 60 43% 31 40 29% 31 38 23%
T, P. F 45 41 59 44% 26 46 77% 22 73 232% 17 27 59% 26 32 23%
W, P. F 65 48 76 58% 17 31 82% 9 21 133% 9 11 22% 20 19 -3%
W, B. M 38 54 72 33% 42 58 38% 32 46 44% 25 37 48% 37 50 35%
W, R. M 40 77 77 0% 34 41 21% 27 33 22% 12 16 33% 21 24 14%
W, C. F 55 28 39 39% 20 28 40% 17 26 53% 12 16 33% 20 23 15%
W, G. F 70 101 108 7% 78 98 26% 34 82 141% 51 65 27% 49 62 27%
Z, A. F 43 62 75 21% 64 75 17% 107 87 -19% 68 88 29% 57 49 -14%
Average:   52 60 76 28% 48 65 38% 50 72 44% 35 54 54% 48 70 44%
Average Overall Improvement 45%             
  1. Results were measured as percentage improvement of the percentage predicted on the Knudsen scale